Major U.S. stock indexes were higher at midday as markets awaited more information about potential White House tariff deals.

Companies are developing myostatin inhibitors for GLP-1RA- related muscle loss, but some experts doubt their necessity.

A team of Bentonville West High School students is being recognized nationally for developing an app capable of detecting ...

President Trump’s proposed 25% tariff on pharmaceutical imports, largely from Ireland, could raise U.S. drug costs by nearly ...

Earth Day 2025 calls for a bold global effort to triple renewable electricity generation by 2030. The world of sport is ...

A total of 19,323 images from TBP (61 per patient ... Almirall, ISDIN, BMS, Regeneron, Philogen, Pierre Fabre, and La Roche-Posay.

Phase Ib results show VERVE-102 reduced LDL-C levels with no serious safety issues, unlike Verve’s VERVE-101 programme.

Oncology Clinical Trial Market Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to ...

Paz, astonished, was awarded $250,000 under the Regeneron Science Talent Search for this ... an AI to detect skin cancer by analysing 130,000 historical dermatology images, and it has since become as ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.